Invention Grant
- Patent Title: Predictive biomarker for cancer therapy
-
Application No.: US14891869Application Date: 2014-05-15
-
Publication No.: US10006032B2Publication Date: 2018-06-26
- Inventor: Matthias Schroff , Manuel Schmidt , Kerstin Kapp , Burghardt Wittig
- Applicant: Mologen AG
- Applicant Address: DE Berlin
- Assignee: Mologen AG
- Current Assignee: Mologen AG
- Current Assignee Address: DE Berlin
- Agency: Sughrue Mion, PLLC
- Priority: GB1309657.3 20130530
- International Application: PCT/EP2014/059995 WO 20140515
- International Announcement: WO2014/191222 WO 20140412
- Main IPC: C12N15/117
- IPC: C12N15/117 ; G01N33/50 ; G01N33/574 ; A61K39/39
Abstract:
The present invention relates generally to the identification of patients suffering from cancer whether they will respond to specific therapies. More particularly the invention relates to a method and means for identifying responder to a therapy TLR-9 agonists.
Public/Granted literature
- US20160115479A1 Predictive Biomarker for Cancer Therapy Public/Granted day:2016-04-28
Information query
IPC分类:
